Posted inGenetics
Vir Biotechnology Pivots to Cancer, Infectious Disease after Commercial and Clinical Setbacks
Marianne De Backer, PhD, MBA, CEO of Vir Biotechnology, has led the company's pivot to focusing on cancer as well…
Posted inBiotechnology
Allogene reports patient death, discontinues investigational antibody in CAR-T pivotal trial
Allogene Therapeutics has reported a patient death tied to its anti-CD52 monoclonal antibody used for lymphodepletion in its key CAR-T…
Posted inBiotechnology
Protecting Desert Ecosystems: A New Book Delves Into Mexico’s Vulnerable Arid Regions
The arid and semi-arid zones of Mexico represent a unique tapestry of biodiversity, ecological complexity, and pressing conservation challenges. In…
Posted inBiotechnology
New Book Investigates How Antibiotics Affect Women’s Reproductive Health
Bentham Science Publisher’s latest scholarly release, Antibiotics and Reproductive Health, emerges as an essential compendium at the crossroads of pharmacology,…
Posted inBiotechnology
Chutes & Ladders—Novo Nordisk nominates CEO successor
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Posted inBiotechnology
Multiomics Uncovers Key Heart Failure Targets
In an unprecedented leap forward in cardiac research, a groundbreaking study has unveiled new dimensions of understanding the human heart’s…
Posted inBiotechnology
Standardizing Low-Dose Platelet Transfusions for Infants
In neonatal intensive care units worldwide, platelet transfusions are a critical, life-saving intervention for vulnerable infants with thrombocytopenia or bleeding…
Posted inBiotechnology
α-Synuclein Fibril Structure Drives Parkinson’s Seeding
In the relentless pursuit to unravel the mysteries behind Parkinson’s disease, a groundbreaking study has emerged that shines new light…
Posted inBiotechnology
Not All Low-Grade Prostate Cancers Pose Low Risk, Study Finds
A groundbreaking new study, spearheaded by experts from Weill Cornell Medicine, University Hospitals Cleveland, and Case Western Reserve University, challenges…
Posted inBiotechnology
Examining the Link Between GLP-1 Receptor Agonists and Nonarteritic Anterior Ischemic Optic Neuropathy Risk in Older Adults with Diabetes
A newly published study focusing on Medicare beneficiaries aged 65 and older with type 2 diabetes has identified a noteworthy…